BioInvent Receives €0.75 Million Milestone Under Mitsubishi Tanabe Pharma Partnership

By In The News
April 26, 2019 in The Headlines

Recommended Posts

In The News

Posted April 26, 2019

- Share

Posted April 26, 2019

LUND, Sweden, April 26, 2019 /PRNewswire/ -- BioInvent International AB (OMXS: BINV) announced today that it has received a €0.75 million milestone payment under its collaboration with Mitsubishi Tanabe Pharma Corporation in connection with enrollment of the first patient in a Phase II...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  222076
2. Jaydee
  17809
3. deicer
  13357
4. Kip Powick
  12315
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.5k
- Total Posts
  
  565.1k

Sign In

BioInvent Receives €0.75 Million Milestone Under Mitsubishi Tanabe Pharma Partnership

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support